Stay updated on ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedNew quick links 'Check who can join' and 'Find Contact Information' appear on the record history page, facilitating eligibility checks and contact access. The revision note now shows Revision: v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.5%

- Check15 days agoChange DetectedThe version history now shows a new release entry for v3.5.5, replacing the previous v3.5.4. This reflects a backend/UI update without changes to the study details.SummaryDifference0.1%

- Check36 days agoChange DetectedThe Record History now includes a new Revision: v3.5.4 entry as part of the version history, and the previous Revision: v3.5.3 entry has been removed from the list. This reflects a minor site release update rather than any change to trial data or descriptions.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page’s developer/version footer was updated from Revision v3.5.2 to v3.5.3, reflecting a site release rather than a study record change.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded revision: v3.5.2 and removed revision: v3.5.0 from the record history.SummaryDifference0.1%

- Check93 days agoChange DetectedAdded Revision: v3.5.0 and deleted Revision: v3.4.3 in the Record History.SummaryDifference0.1%

Stay in the know with updates to ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.